NTEC Neose Technologies Inc. featured news, full reports, and detailed charts
Neose Technologies Inc. (NTEC/NTEC.PK) Wrap Up:
Neose Technologies, Inc. operates under a plan of liquidation that was approved in January 2009. Previously, the company operated as a clinical-stage biopharmaceutical company that focused on the development of next-generation therapeutic proteins. The company?s products were developed based on the GlycoPEGylation technology that involved the use of enzymes to attach PEG to carbohydrate structures on proteins. Its therapeutic protein candidates in development stage included GlycoPEG-GCSF, a phase-I completed product, for the treatment of neutropenia associated with myelosuppressive chemotherapy; and GlycoPEG-FVIIa for the treatment of bleeding episodes and for the prevention of bleeding during surgery or invasive procedures in patients with congenital hemophilia with inhibitors to coagulation factors VIII or IX. Neose Technologies, Inc. was founded in 1989 and is headquartered in Horsham, Pennsylvania.Neose Technologies Inc. (NTEC:OTC)
|
Market Cap
4.4M
|
Total Revenue
10.4M
|
|
|
EBITDA
19.0M
|
DILUTED EPS TTM
-0.27
|
|
|
P/E
--
|
P/S
0.4x
|
|
|
Return On Asset
-38.34
|
Return On Equity
-98.57
|
|
| K = Thousands M = Millions B = Billions | ||
NTEC Top Compensated Officers
Executives, Board Directors
Key developments for Neose Technologies Inc. (NTEC)
Neose Technologies Inc. announced that, in accordance with the Plan of Complete Liquidation and Dissolution approved by its stockholders on January 26, 2009, its Board of Directors has approved an initial liquidating distribution in the amount of $0.33 per share of common stock. The Initial Distribution is expected to be made on or about March 24, 2009 to stockholders of record as of the close of business on March 2, 2009.
Neose Technologies Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common stock under the Securities Exchange Act of 1934, as amended. The par value of the company's common stock was $0.01 per share.
Neose Technologies, Inc. announced that it has filed with the Securities and Exchange Commission (SEC) a Form 25 relating to the delisting of its common stock from the NASDAQ Global Market. The NASDAQ Stock Market will suspend trading in the Stock effective at the open of business on March 3, 2009, with official delisting of the Stock becoming effective ten days thereafter, on March 13, 2009.
NTEC Competitors
| Company | Last | Change |
| Affymax Inc | $20.07 USD | +0.41 |
| ARIAD Pharmaceuticals Inc | $2.16 USD | -0.03 |
| Biovitrum | kr62.00 SEK | +1.00 |
| Enzon Pharmaceuticals Inc | $10.32 USD | -0.07 |
| Maxygen Inc | $5.62 USD | +0.04 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | NTEC | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.4x |
|
| Price/Book | 0.6x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
NTEC |
||
NTEC transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About Neose Technologies Inc.
More news for NTEC
NEOSE TECHNOLOGIES INC Financials
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...Click here to read the whole Article (external link)
NEOSE TECHNOLOGIES INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stan
Show all filings for NEOSE TECHNOLOGIES INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for NEOSE TECHNOLOGIES INC 3-Mar-2009Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stan Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information...Click here to read the whole Article (external link)
NEOSE TECHNOLOGIES INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stan
Show all filings for NEOSE TECHNOLOGIES INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for NEOSE TECHNOLOGIES INC 20-Feb-2009Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stan Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information pro...Click here to read the whole Article (external link)
NEOSE TECHNOLOGIES INC Financials
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...Click here to read the whole Article (external link)
